Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP435482.RAOLHbV8vnd2wYM6N0IgAZ0pC21NqJfYJuohXeWTVysBs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP435482.RAOLHbV8vnd2wYM6N0IgAZ0pC21NqJfYJuohXeWTVysBs130_assertion type Assertion NP435482.RAOLHbV8vnd2wYM6N0IgAZ0pC21NqJfYJuohXeWTVysBs130_head.
- NP435482.RAOLHbV8vnd2wYM6N0IgAZ0pC21NqJfYJuohXeWTVysBs130_assertion description "[The scenarios involve glutathione-S-transferase theta 1 (GSTT1) and hematopoietic cancer in hospital workers, human leukocyte antigen coding for glutamic acid in the 69th position (HLA DPB1(E69)) and chronic beryllium disease in beryllium workers, and peripheral myelin protein 22 (PMP22) deletion and carpal tunnel syndrome in railroad track workers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435482.RAOLHbV8vnd2wYM6N0IgAZ0pC21NqJfYJuohXeWTVysBs130_provenance.
- NP435482.RAOLHbV8vnd2wYM6N0IgAZ0pC21NqJfYJuohXeWTVysBs130_assertion evidence source_evidence_literature NP435482.RAOLHbV8vnd2wYM6N0IgAZ0pC21NqJfYJuohXeWTVysBs130_provenance.
- NP435482.RAOLHbV8vnd2wYM6N0IgAZ0pC21NqJfYJuohXeWTVysBs130_assertion SIO_000772 15018031 NP435482.RAOLHbV8vnd2wYM6N0IgAZ0pC21NqJfYJuohXeWTVysBs130_provenance.
- NP435482.RAOLHbV8vnd2wYM6N0IgAZ0pC21NqJfYJuohXeWTVysBs130_assertion wasDerivedFrom befree-2016 NP435482.RAOLHbV8vnd2wYM6N0IgAZ0pC21NqJfYJuohXeWTVysBs130_provenance.
- NP435482.RAOLHbV8vnd2wYM6N0IgAZ0pC21NqJfYJuohXeWTVysBs130_assertion wasGeneratedBy ECO_0000203 NP435482.RAOLHbV8vnd2wYM6N0IgAZ0pC21NqJfYJuohXeWTVysBs130_provenance.